NASDAQ
Roivant Sciences Ltd. (ROIV) has a price/sales ratio of 2326.88x as of Friday, May 22, 2026. This represents a 1177.92% increase compared to its 12-month average of 182.08x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.